Home › Ovarian Epithelial Carcinoma › Rhode Island › Providence
Ovarian Epithelial Carcinoma clinical trials in Providence, RI
3 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecruitingPhase 2
- Women & Infants Hospital /ID# 274716, Providence
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
RecruitingPhase 1
- Site 0191, Providence
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RecruitingPhase 1
- Rhode Island Hospital, Providence
Ovarian Epithelial Carcinoma trials in other cities
- Durham, NC8 studies
- Boston, MA8 studies
- Chicago, IL7 studies
- San Diego, CA7 studies
- New York City, NY7 studies
- Baltimore, MD6 studies
- Philadelphia, PA6 studies
- Houston, TX6 studies
- Cleveland, OH6 studies
- Los Angeles, CA5 studies
- Edison, NJ5 studies
- Minneapolis, MN5 studies
Other studies in Providence
- Ovarian Cancer15 studies
- Endometrial Cancer14 studies
- Obesity14 studies
- Non-Small Cell Lung Cancer12 studies
- Cancer (all types)12 studies
- Crohn's Disease12 studies
- Ulcerative Colitis11 studies
- Breast Cancer11 studies
- Acute Myeloid Leukemia10 studies
- Metastatic Cancer9 studies
- Overweight9 studies
- Alzheimer's Disease8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.